CVAT vs IVPR
Cavitation Technologies, Inc. and Inspire Veterinary Partners, Inc., side by side — 3 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | CVAT | IVPR |
|---|---|---|
| Revenue | $203,000 | $16.6M |
| Net income | $-113,000 | $-14.3M |
| Gross margin | 81.3% | — |
| Net margin | −55.7% | −86.0% |
| Return on equity | −3487.2% | −3687.1% |
| Diluted EPS | $0.00 | — |
| Dividend / share | — | — |
| Payout ratio | — | — |
| Free cash flow | $-378,000 | $-10.2M |
| Equity | $69,000 | $1.6M |
| Net debt / equity | −1.78× | 7.34× |
| Current ratio | 2.80× | 0.25× |
| Revenue CAGR 5y | −34.3% | — |
| Profit CAGR 5y | — | — |
IVPR bills 81.7× the revenue of CVAT, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
3 years side by side
| Fiscal year | CVAT | IVPR |
|---|---|---|
| FY2024 | $203,000 | $16.6M |
| FY2023 | $1.4M | $16.7M |
| FY2022 | $433,000 | $9.8M |
Net income by year
Bottom line
| Fiscal year | CVAT | IVPR |
|---|---|---|
| FY2024 | $-113,000 | $-14.3M |
| FY2023 | $439,000 | $-14.8M |
| FY2022 | $-2.0M | $-4.9M |
Advertisement
AdSense · Rectangle 336×280
The companies